<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02300740</url>
  </required_header>
  <id_info>
    <org_study_id>45141</org_study_id>
    <nct_id>NCT02300740</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic Analysis of Nicotinamide Riboside</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <brief_summary>
    <textblock>
      Nicotinamide riboside is a newly discovered vitamin B3. The pharmacokinetics in humans is so
      far not analyzed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum nicotinamide riboside</measure>
    <time_frame>8 hours, blood samples every 15 min</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum concentrations of metabolites of nicotinamide riboside</measure>
    <time_frame>8 hour, blood samples every 15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>area under the curve for serum nicotinamide riboside</measure>
    <time_frame>8 hours, blood samples every 15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calculation of halftime of serum nicotinamide riboside</measure>
    <time_frame>8 hours, blood samples every 15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calculation of C-max of serum nicotinamide riboside</measure>
    <time_frame>8 hours, blood samples every 15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calculation of t-max of serum nicotinamide riboside</measure>
    <time_frame>8 hours, blood samples every 15 min</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy Participants</condition>
  <arm_group>
    <arm_group_label>low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>500 mg nicotinamide riboside oral</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1000 mg nicotinamide riboside oral</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nicotinamide riboside</intervention_name>
    <description>NIAGEN, ChromaDex</description>
    <arm_group_label>low dose</arm_group_label>
    <arm_group_label>high dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 18-25, healthy, male,

        Exclusion Criteria:

          -  liver or kidney diseases, other diseases
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical Research Laboratories, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2014</study_first_submitted>
  <study_first_submitted_qc>November 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2014</study_first_posted>
  <last_update_submitted>February 26, 2015</last_update_submitted>
  <last_update_submitted_qc>February 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Britt Christensen</investigator_full_name>
    <investigator_title>Cand.Scient, PhD, Post doc</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Niacinamide</mesh_term>
    <mesh_term>Niacin</mesh_term>
    <mesh_term>Nicotinic Acids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

